USPTO Examiner ALTER MORSCHAUSER ALYSSA MARGO - Art Unit 3796

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19002188NEUROSTIMULATION THERAPY FOR TREATING UTERINE BLEEDINGDecember 2024June 2025Allow510YesNo
18902006DELIVERY OF NON-PENETRATING ELECTRICAL NEUROSTIMULATION THERAPYSeptember 2024July 2025Allow920YesNo
18810423SYSTEM AND METHODS FOR MODULATING NERVE ACTIVATIONAugust 2024January 2026Allow1720YesNo
18771567IMPLANTABLE MEDICAL DEVICE FIXATIONJuly 2024January 2025Allow610NoNo
18766408Sensory Control SystemJuly 2024November 2025Abandon1620NoNo
18747310TREATMENT OF NEURODEGENERATIVE DISEASE WITH HIGH FREQUENCY STIMULATION, AND ASSOCIATED SYSTEMS AND METHODSJune 2024March 2026Allow2010YesNo
18675492Wearable Auricular Neurostimulator and Methods of UseMay 2024February 2025Allow920YesNo
18628866PUMP ARRANGEMENTApril 2024October 2025Allow1810NoNo
18691874PERIPHERAL NERVE ACTIVATION AND BLOCKING USING CUFF ASSEMBLY AND SINUSOIDAL LOW FREQUENCY ALTERNATING CURRENTMarch 2024June 2025Allow1520YesYes
18594082ADAPTIVE CLOSED-LOOP DBS STIMULATION CONTROLMarch 2024January 2025Allow1010YesNo
18409646METHOD AND APPARATUS FOR INJURY TREATMENTJanuary 2024September 2025Allow2120NoNo
18405686STIMULATION SYSTEMS AND RELATED USER INTERFACESJanuary 2024March 2026Allow2620NoNo
18391128IMPLANTATION OF NEUROSTIMULATORSDecember 2023February 2026Allow2600NoNo
18531735MULTIMODAL CRANIAL NERVE STIMULATION TREATMENT SYSTEM AND METHOD FOR PERSONALIZED OPTIMAL REHABILITATIONDecember 2023December 2025Allow2410NoNo
18530806WATER RESISTANT WEARABLE MEDICAL DEVICEDecember 2023February 2025Allow1410NoNo
18564761FATIGUE ESTIMATION DEVICE, FATIGUE ESTIMATION METHOD, AND STORAGE MEDIUMNovember 2023March 2026Allow2810YesNo
18511644System And Related Method for Positioning of Surgically Implanted Neuro Stimulation Device ElectrodesNovember 2023December 2024Allow1310NoNo
18506521IMPELLER FOR CATHETER PUMPNovember 2023November 2025Allow2410NoNo
18496958MEDICAL ANCHORING APPARATUSOctober 2023May 2024Allow610NoNo
18368800SELECTIVE NEUROMODULATION APPARATUSSeptember 2023October 2024Allow1320YesNo
18466399Closed Loop Control in Spinal Cord Stimulation Therapy with Non-detectable Neural ResponsesSeptember 2023April 2025Allow1910NoNo
18458864POSITIONING OF ELECTRODES FOR TRANSCRANIAL BRAIN STIMULATIONAugust 2023October 2024Allow1420NoNo
18238700RELAY MODULE FOR IMPLANTAugust 2023July 2025Allow2210NoNo
18236643SYSTEMS AND METHODS TO PLACE ONE OR MORE LEADS IN TISSUE TO ELECTRICALLY STIMULATE NERVES OF PASSAGE TO TREAT PAINAugust 2023January 2026Allow2921NoNo
18231071PERIPHERAL NERVE STIMULATION CONTROLAugust 2023January 2026Allow3020YesYes
18230417NEUROSLEEVE FOR CLOSED LOOP EMG-FES BASED CONTROL OF PATHOLOGICAL TREMORSAugust 2023March 2025Allow1910NoNo
18358961TRANSVENOUS INTRACARDIAC PACING CATHETER HAVING IMPROVED LEADSJuly 2023February 2024Allow711NoNo
18225174MINIATURE ECG DATA ACQUISITION DEVICEJuly 2023March 2024Allow810NoNo
18357476SYSTEMS AND METHODS FOR CONTROLLING DEVICE FUNCTIONALITY BASED ON DETERMINED REAL-WORLD ATTRIBUTES OF AN ENVIRONMENTJuly 2023February 2026Abandon3110NoNo
18225001System for Pain Relief With TENS unit, garment, and Optional HeatJuly 2023January 2026Abandon3010NoNo
18355401METHODS FOR REDUCING BLEEDING IN HEMOPHILIA BY VAGUS NERVE STIMULATION TO PRIME PLATELETSJuly 2023January 2026Allow3010YesNo
18213573DEVICES AND METHODS FOR TREATING EDEMAJune 2023November 2024Allow1710NoNo
18256394A SYSTEM COMPRISING A CONTROLLER AND AN ELECTRICAL STIMULATION SYSTEMJune 2023February 2026Allow3310YesNo
18255709ELECTRONIC IMPLANT FOR NEUROMUSCULAR STIMULATIONJune 2023January 2026Allow3210NoNo
18318125LIGHT EMITTING HAIR GROWTH MANAGEMENT DEVICE COMPANION APPLICATIONMay 2023January 2026Allow3210YesNo
18195853METHOD AND APPARATUS FOR SUBTRACTION-BASED PROGRAMMING OF NEUROSTIMULATION FIELDSMay 2023June 2025Allow2520NoNo
18139230MEDIATION OF TRAUMATIC BRAIN INJURYApril 2023December 2025Allow3130YesNo
18304872SYSTEMS FOR COMPARATIVE ANALYSIS OF CARDIAC INFORMATIONApril 2023November 2025Allow3010YesNo
18297104SYSTEM AND METHOD FOR CONSERVING POWER IN A MEDICAL DEVICEApril 2023January 2025Allow2210NoNo
18130488NEUROSLEEVE FOR ASSESSMENT OF PATHOLOGICAL TREMORSApril 2023October 2023Allow720NoNo
18185659ENHANCED TELEMETRY OF A MEDICAL SYSTEM VIA IMPROVED LINK QUALITY FOR A MEDICAL DEVICEMarch 2023September 2025Allow3010YesNo
18171605Signaling Error Conditions in an Implantable Medical Device System Using Simple Charging Coil TelemetryFebruary 2023April 2024Allow1410NoNo
18021358GARMENTS FOR ELECTRICAL STIMULATIONFebruary 2023November 2025Abandon3310NoNo
18104120NEUROSTIMULATION SYSTEM WITH NEURODEGENERATIVE DISEASE DETECTIONJanuary 2023December 2024Allow2310NoNo
18153862System and Method for Adaptive Neural StimulationJanuary 2023July 2025Allow3010YesNo
18153839Pulsed Passive Charge Recovery Circuitry for an Implantable Medical DeviceJanuary 2023December 2024Allow2410YesNo
18095233SYSTEMS AND METHODS FOR AUTOMATIC SUB-PERCEPTION PARAMETER SELECTIONJanuary 2023September 2025Allow3210NoNo
18145780ELECTRODE DEVICES FOR NEUROSTIMULATIONDecember 2022July 2025Allow3120YesYes
18145226MODULAR ELECTRICAL THERAPY DEVICEDecember 2022November 2024Allow2310NoNo
18069689HIGH-FREQUENCY LOW DUTY CYCLE PATTERNS FOR NERUAL REGULATIONDecember 2022April 2025Allow2820YesYes
18069218MULTI-THRESHOLD SENSING OF CARDIAC ELECTRICAL SIGNALS IN AN IMPLANTABLE MEDICAL DEVICEDecember 2022September 2024Allow2110NoNo
18085270PAIN MANAGEMENT BASED ON EMOTIONAL EXPRESSION MEASUREMENTSDecember 2022September 2024Allow2110NoNo
18001910Medical Handling SetDecember 2022August 2025Allow3210NoNo
18075868METHODS AND SYSTEMS FOR MONITORING OR ASSESSING MOVEMENT DISORDERS OR OTHER PHYSIOLOGICAL PARAMETERS USING A STIMULATION SYSTEMDecember 2022December 2025Allow3611YesNo
17955478AUTOMATIC SELECTION OF PARAMETERS OF AN EXPOSURE MODE OF AN IMPLANTABLE MEDICAL DEVICESeptember 2022September 2024Allow2410NoNo
17893924Neuromodulation of GangliaAugust 2022July 2024Allow2330NoNo
17892708DEVICE AND METHOD TO MODULATE A NERVOUS SYSTEM STRUCTURE TO NON-INVASIVELY AND NON-DESTRUCTIVELY INHIBIT NERVOUS SIGNALINGAugust 2022November 2024Allow2710YesNo
17882923Seamlessly Embedded Heart Rate MonitorAugust 2022November 2023Allow1520YesNo
17867264FUNCTIONAL GARMENTS AND METHODS THEREOFJuly 2022June 2024Abandon2310NoNo
17842650SYSTEMS AND METHODS FOR ACUTE AND CHRONIC PAIN MANAGEMENTJune 2022October 2024Abandon2810NoNo
17832099ELECTROSURGICAL METHODS AND SYSTEMSJune 2022June 2025Abandon3620YesNo
17727883SYSTEMS AND METHODS TO PLACE ONE OR MORE LEADS IN TISSUE TO ELECTRICALLY STIMULATE NERVES TO TREAT PAINApril 2022March 2024Allow2310NoNo
17723315SPINAL CORD STIMULATOR ELECTRODE POSITIONING SYSTEM UTILIZING AN ALGORITHM FOR FILTERING ELECTROMYOGRAPHY DATAApril 2022March 2026Allow4730YesNo
17723207METHODS AND SYSTEMS FOR DETERMINING WHETHER R-WAVE DETECTIONS SHOULD BE CLASSIFIED AS FALSE DUE TO T-WAVE OVERSENSING (TWO) OR P-WAVE OVERSENSING (PWO)April 2022May 2025Allow3710YesNo
17704051NON-INVASIVE NEUROMODULATION (NINM) FOR REHABILITATION OF BRAIN FUNCTIONMarch 2022April 2024Allow2510NoNo
17649574SYSTEMS AND METHODS FOR DETECTING HEALTH DISORDERSFebruary 2022February 2024Allow2410NoNo
17629428SYSTEMS AND METHODS FOR SUSTAINED RELIEF OF CHRONIC PAINJanuary 2022August 2025Allow4221NoNo
17644155PEDIATRIC AND ADULT DEFIBRILLATORDecember 2021January 2024Allow2510NoNo
17542229SYSTEM AND METHOD FOR MONITORING BIOMETRIC SIGNALSDecember 2021April 2024Abandon2810NoNo
17596074BiosensorDecember 2021May 2025Abandon4121YesNo
17456252AMBULATORY MEDICAL DEVICE INTERACTIONNovember 2021October 2025Allow4721YesNo
17516452METHOD FOR USING A SINUS TREATMENT DEVICENovember 2021August 2025Allow4520YesNo
17499113PUMP ARRANGEMENTOctober 2021January 2024Allow2710NoNo
17481127SYSTEMS AND METHODS FOR DORSAL NERVE ROOT STIMULATIONSeptember 2021July 2024Allow3410NoNo
17479432CARDIAC RESYNCHRONIZATION THERAPY DIAGNOSTICSSeptember 2021December 2023Allow2710NoNo
17447489WATER RESISTANT WEARABLE MEDICAL DEVICESeptember 2021October 2023Allow2510NoNo
17472408CATHETER APPARATUSES HAVING MULTI-ELECTRODE ARRAYS FOR RENAL NEUROMODULATION AND ASSOCIATED SYSTEMS AND METHODSSeptember 2021November 2024Allow3830YesNo
17463327Transvenous Intracardiac Pacing CatheterAugust 2021September 2023Allow2510YesNo
17458004Systems and Methods for Transcranial Light TherapyAugust 2021February 2026Allow5421YesNo
17410953TREATMENT OF NEURODEGENERATIVE DISEASE WITH HIGH FREQUENCY STIMULATION, AND ASSOCIATED SYSTEMS AND METHODSAugust 2021June 2024Abandon3410NoNo
17408890Method and System for Automated Neuromodulation through Machine LearningAugust 2021January 2025Allow4021NoNo
17406822DEVICES AND METHODS FOR ENDOLUMINAL DELIVERY OF EITHER FLUID OR ENERGY FOR DENERVATIONAugust 2021August 2025Allow4830YesNo
17431139SYSTEM FOR PROVIDING NEUROMODULATION, ESPECIALLY NEUROSTIMULATIONAugust 2021March 2025Abandon4320YesNo
17401054USING MULTIPLE DIAGNOSTIC PARAMETERS FOR PREDICTING HEART FAILURE EVENTSAugust 2021February 2024Abandon3010NoNo
17387831TRIAL NEUROSTIMULATION SYSTEM WITH A LEAD ADAPTERJuly 2021August 2023Allow2510NoNo
17385665PATIENT-SPECIFIC CALIBRATION OF PAIN QUANTIFICATIONJuly 2021October 2024Allow3830YesNo
17380906IMPLANTABLE MEDICAL DEVICE WHICH MAY BE CONTROLLED FROM CENTRAL STATIONJuly 2021March 2025Allow4420NoNo
17305792WEARABLE NEUROSTIMULATION SYSTEM WITH CURATED THERAPYJuly 2021May 2024Allow3410NoNo
17374347RING ELECTRODE WITH INTERMEDIATE DIFFUSION LAYERJuly 2021April 2024Allow3310YesNo
17369035SYSTEMS AND METHODS FOR DETERMINING SPINAL CORD STIMULATION PARAMETERS BASED ON PATIENT FEEDBACKJuly 2021June 2024Allow3520NoYes
17357836DEVICES AND SYSTEMS FOR ELECTRICAL STIMULATION AND METHODS OF USEJune 2021December 2023Allow2910NoNo
17353887DEVICE FOR ELECTRICAL STIMULATION OF PERIDONTAL COMPLEX AND SURROUNDING TISSUEJune 2021January 2024Allow3020NoNo
17331142MULTI-SITE NEUROMODULATION FOR TREATMENT OF ALS AND RELATED DISORDERSMay 2021December 2024Allow4321NoNo
17327926IMPLANTABLE DEVICE FOR PROVIDING ELECTRICAL STIMULATION OF CERVICAL VAGUS NERVES FOR TREATMENT OF CHRONIC CARDIAC DYSFUNCTIONMay 2021September 2023Allow2710NoNo
17193725Method and Apparatus for Injury TreatmentMarch 2021October 2023Allow3120YesNo
17188437NEUROPSYCHOLOGICAL AND NEUROLOGICAL REHABILITATION HEADGEAR DEVICEMarch 2021August 2023Allow3020YesNo
17272217IMPLANTABLE CLOSED-LOOP NEUROMODULATION DEVICE, SYSTEMS, AND METHODS OF USEFebruary 2021September 2023Allow3120YesNo
17187707MONITORING DEVICE, AND MONITORING INFORMATION DISPLAY METHOD AND APPARATUSFebruary 2021September 2025Abandon5540YesNo
17177519LVAD FIXATION AND INFECTION MANAGEMENTFebruary 2021July 2025Abandon5341YesNo
17174014SYSTEM AND METHOD FOR QUANTIFYING QUALITATIVE PATIENT-REPORTED DATA SETSFebruary 2021August 2023Allow3010YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner ALTER MORSCHAUSER, ALYSSA MARGO.

Strategic Value of Filing an Appeal

Total Appeal Filings
8
Allowed After Appeal Filing
2
(25.0%)
Not Allowed After Appeal Filing
6
(75.0%)
Filing Benefit Percentile
36.6%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 25.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner ALTER MORSCHAUSER, ALYSSA MARGO - Prosecution Strategy Guide

Executive Summary

Examiner ALTER MORSCHAUSER, ALYSSA MARGO works in Art Unit 3796 and has examined 95 patent applications in our dataset. With an allowance rate of 88.4%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 36 months.

Allowance Patterns

Examiner ALTER MORSCHAUSER, ALYSSA MARGO's allowance rate of 88.4% places them in the 69% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.

Office Action Patterns

On average, applications examined by ALTER MORSCHAUSER, ALYSSA MARGO receive 2.34 office actions before reaching final disposition. This places the examiner in the 66% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by ALTER MORSCHAUSER, ALYSSA MARGO is 36 months. This places the examiner in the 38% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a -2.1% benefit to allowance rate for applications examined by ALTER MORSCHAUSER, ALYSSA MARGO. This interview benefit is in the 9% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 32.8% of applications are subsequently allowed. This success rate is in the 70% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 31.4% of cases where such amendments are filed. This entry rate is in the 46% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 23% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 100% percentile among all examiners. Of these withdrawals, 60.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 70.8% are granted (fully or in part). This grant rate is in the 78% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 2.1% of allowed cases (in the 75% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 51% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.